Pediatrics
Professor
Phase III, stratified, randomized observer blind controlled multicenter clinical study to evaluate the safety immunogenicity and efficacy of an adjuvanted quadrivalent subunit influenza virus vaccine compared to non-adjuvanted comparator in children 6 months to less than 72 months of age